tirzepatide surpass-5 reduces albuminuria among adults with type 2 diabetes in SURPASS trials Tirzepatide Matches Dulaglutide in Large

"The issue with companies that are just really experiencing super strong growth in the near-term is that people tend to extrapolate that longer term," said Andersen, "and that's when you actually model it out." Andersen, whose company specializes on long-term forecasts rather than short-term predictions typical of Wall Street, noted that Lilly and Novo may see increased price competition as early as 2026

Reduced insulin levels can lead to decreased androgen production and increased SHBG, potentially reducing sebum production and acne severity in susceptible individuals

Its actions remain relevant due to its part in the drugs history and development

The comparison is therefore not about which stimulates more GH, but about how much off-target endocrine activity a research design can tolerate.